Skip to main content
Erschienen in: Strahlentherapie und Onkologie 4/2018

18.01.2018 | Original Article

Quality of training in radiation oncology in Germany: where do we stand?

Results from a 2016/2017 survey performed by the working group “young DEGRO” of the German society of radiation oncology (DEGRO)

verfasst von: Dr. med. C. T. Dietzel, K. Jablonska, M. Niyazi, T. Gauer, N. Ebert, C. Ostheimer, D. Krug

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the current situation of young radiation oncologists in Germany with regard to the contents and quality of training and level of knowledge, as well as their working conditions and professional satisfaction.

Methods

From June 2016 to February 2017, a survey was conducted by the young DEGRO (yDEGRO) using an online platform. The questionnaire consisted of 28 items examining a broad range of aspects influencing residency. There were 96 completed questionnaires

Results

83% of participants stated to be very or mostly pleased with their residency training. Moderate working hours and a good colleagueship contribute to a comfortable working environment. Level of knowledge regarding the most common tumor sites (i.e. palliative indications, lung, head and neck, brain, breast, prostate) was pleasing. Radiochemotherapy embodies a cornerstone in training. Modern techniques such as intensity-modulated radiotherapy (IMRT) and stereotactic procedures are now in widespread use. Education for rare indications and center-based procedures offers room for improvement.

Conclusion

Radiation oncology remains an attractive and versatile specialty with favorable working conditions. Continuing surveys in future years will be a valuable measuring tool to set further priorities in order to preserve and improve quality of training.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, Malicki J, Bogusz M, Gasparotto C, Grau C, Kokobobo A, Sedlmayer F, Slobina E, Coucke P, Gabrovski R, Vosmik M, Eriksen JG, Jaal J, Dejean C, Polgar C, Johannsson J, Cunningham M, Atkocius V, Back C, Pirotta M, Karadjinovic V, Levernes S, Maciejewski B, Trigo ML, Šegedin B, Palacios A, Pastoors B, Beardmore C, Erridge S, Smyth G, Cleries Soler R, Consortium H (2014) Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112(2):178–186. https://doi.org/10.1016/j.radonc.2014.08.034 CrossRefPubMed Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, Malicki J, Bogusz M, Gasparotto C, Grau C, Kokobobo A, Sedlmayer F, Slobina E, Coucke P, Gabrovski R, Vosmik M, Eriksen JG, Jaal J, Dejean C, Polgar C, Johannsson J, Cunningham M, Atkocius V, Back C, Pirotta M, Karadjinovic V, Levernes S, Maciejewski B, Trigo ML, Šegedin B, Palacios A, Pastoors B, Beardmore C, Erridge S, Smyth G, Cleries Soler R, Consortium H (2014) Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112(2):178–186. https://​doi.​org/​10.​1016/​j.​radonc.​2014.​08.​034 CrossRefPubMed
8.
Zurück zum Zitat Meredith RF, Eisert DR (1987) 1986 Association of Residents in Radiation Oncology Survey. Int J Radiat Oncol Biol Phys 13(12):1893–1895CrossRefPubMed Meredith RF, Eisert DR (1987) 1986 Association of Residents in Radiation Oncology Survey. Int J Radiat Oncol Biol Phys 13(12):1893–1895CrossRefPubMed
11.
Zurück zum Zitat Krug D, Baumann R, Rieckmann T, Fokas E, Gauer T, Niyazi M (2016) Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries: results from a web-based survey of the Young DEGRO working group. Strahlenther Onkol 192(8):507–515. https://doi.org/10.1007/s00066-016-1003-y CrossRefPubMed Krug D, Baumann R, Rieckmann T, Fokas E, Gauer T, Niyazi M (2016) Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries: results from a web-based survey of the Young DEGRO working group. Strahlenther Onkol 192(8):507–515. https://​doi.​org/​10.​1007/​s00066-016-1003-y CrossRefPubMed
14.
Zurück zum Zitat Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716. https://doi.org/10.1016/S0140-6736(11)61629-2 CrossRefPubMed Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716. https://​doi.​org/​10.​1016/​S0140-6736(11)61629-2 CrossRefPubMed
15.
Zurück zum Zitat Vujovic O, Perera F, Dar AR, Stitt L, Yu E, Voruganti SM, Truong PT (1998) Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys 40(4):869–874CrossRefPubMed Vujovic O, Perera F, Dar AR, Stitt L, Yu E, Voruganti SM, Truong PT (1998) Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys 40(4):869–874CrossRefPubMed
16.
Zurück zum Zitat Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933. https://doi.org/10.1200/JCO.2011.40.1836 CrossRefPubMed Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933. https://​doi.​org/​10.​1200/​JCO.​2011.​40.​1836 CrossRefPubMed
17.
Zurück zum Zitat van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, Group C (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084. https://doi.org/10.1056/NEJMoa1112088 CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, Group C (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084. https://​doi.​org/​10.​1056/​NEJMoa1112088 CrossRefPubMed
18.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330 CrossRefPubMed Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. https://​doi.​org/​10.​1056/​NEJMoa043330 CrossRefPubMed
28.
Zurück zum Zitat Trad M, Johnson J (2014) Bullying among radiation therapists: effects on job performance and work environment. Radiol Technol 86(2):122–131PubMed Trad M, Johnson J (2014) Bullying among radiation therapists: effects on job performance and work environment. Radiol Technol 86(2):122–131PubMed
30.
Zurück zum Zitat Weber HE, Dröge LH, Hennies S, Herrmann MK, Gaedcke J, Wolff HA (2015) Volumetric intensity-modulated arc therapy vs. 3‑dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: effects on treatment-related side effects and survival. Strahlenther Onkol 191(11):827–834. https://doi.org/10.1007/s00066-015-0859-6 CrossRefPubMed Weber HE, Dröge LH, Hennies S, Herrmann MK, Gaedcke J, Wolff HA (2015) Volumetric intensity-modulated arc therapy vs. 3‑dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: effects on treatment-related side effects and survival. Strahlenther Onkol 191(11):827–834. https://​doi.​org/​10.​1007/​s00066-015-0859-6 CrossRefPubMed
41.
Zurück zum Zitat Eriksen JG, Beavis AW, Coffey MA, Leer JW, Magrini SM, Benstead K, Boelling T, Hjälm-Eriksson M, Kantor G, Maciejewski B, Mezeckis M, Oliveira A, Thirion P, Vitek P, Olsen DR, Eudaldo T, Enghardt W, François P, Garibaldi C, Heijmen B, Josipovic M, Major T, Nikoletopoulos S, Rijnders A, Waligorski M, Wasilewska-Radwanska M, Mullaney L, Boejen A, Vaandering A, Vandevelde G, Verfaillie C, Pötter R (2012) The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. Radiother Oncol 103(1):103–108. https://doi.org/10.1016/j.radonc.2012.02.007 CrossRefPubMed Eriksen JG, Beavis AW, Coffey MA, Leer JW, Magrini SM, Benstead K, Boelling T, Hjälm-Eriksson M, Kantor G, Maciejewski B, Mezeckis M, Oliveira A, Thirion P, Vitek P, Olsen DR, Eudaldo T, Enghardt W, François P, Garibaldi C, Heijmen B, Josipovic M, Major T, Nikoletopoulos S, Rijnders A, Waligorski M, Wasilewska-Radwanska M, Mullaney L, Boejen A, Vaandering A, Vandevelde G, Verfaillie C, Pötter R (2012) The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. Radiother Oncol 103(1):103–108. https://​doi.​org/​10.​1016/​j.​radonc.​2012.​02.​007 CrossRefPubMed
Metadaten
Titel
Quality of training in radiation oncology in Germany: where do we stand?
Results from a 2016/2017 survey performed by the working group “young DEGRO” of the German society of radiation oncology (DEGRO)
verfasst von
Dr. med. C. T. Dietzel
K. Jablonska
M. Niyazi
T. Gauer
N. Ebert
C. Ostheimer
D. Krug
Publikationsdatum
18.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 4/2018
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1250-6

Weitere Artikel der Ausgabe 4/2018

Strahlentherapie und Onkologie 4/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.